BETTER DECISIONS FOR EFFICIENT CLINICAL DEVELOPMENT
The Future Lab Dialogues at Walter Klybeck bring together professionals shaping the next generation of life sciences.
In this focused executive edition, InVeVol and Walter Science convene senior decision-makers to explore how earlier choices about patients, evidence and data can improve clinical-trial design and strengthen clinical-development ROI.
Where is value created or lost before a clinical trial begins? How can we leverage technology and best practices for an early optimization of the trial protocols and design?
Clinical trials can lose value when important choices about patient selection, evidence and data are made too late or in isolation.
Brief expert inputs will introduce practical examples involving targeted patient stratification and traceable regulatory and clinical intelligence. These will provide the starting point for a facilitated dialogue on where innovative technologies can meaningfully improve decision quality without adding unnecessary complexity.
This is a focused working session, not a conventional panel discussion or product presentation.
Participants will contribute their perspectives, challenge assumptions and leave with practical insights and valuable connections.
WHO SHOULD
...
show more
BETTER DECISIONS FOR EFFICIENT CLINICAL DEVELOPMENT
The Future Lab Dialogues at Walter Klybeck bring together professionals shaping the next generation of life sciences.
In this focused executive edition, InVeVol and Walter Science convene senior decision-makers to explore how earlier choices about patients, evidence and data can improve clinical-trial design and strengthen clinical-development ROI.
Where is value created or lost before a clinical trial begins? How can we leverage technology and best practices for an early optimization of the trial protocols and design?
Clinical trials can lose value when important choices about patient selection, evidence and data are made too late or in isolation.
Brief expert inputs will introduce practical examples involving targeted patient stratification and traceable regulatory and clinical intelligence. These will provide the starting point for a facilitated dialogue on where innovative technologies can meaningfully improve decision quality without adding unnecessary complexity.
This is a focused working session, not a conventional panel discussion or product presentation.
Participants will contribute their perspectives, challenge assumptions and leave with practical insights and valuable connections.
WHO SHOULD JOIN?
Senior decision-makers across clinical development, biomarkers, clinical operations, regulatory affairs, evidence generation, market access, data and investment.
EVENT OUTLINE
17:30 — Arrival and welcome
17:40 — Innovation at Walter Klybeck
17:50 — Decisions, evidence and trial design
17:55 — Targeted patient stratification
18:10 — Traceable regulatory and clinical intelligence
18:20 — Facilitated executive dialogue
18:55 — Synthesis and next steps
19:00 — Networking drinks
Wednesday, 30 September 2026, 17:30
Walter Klybeck, 5th floor
Klybeckstrasse 161, 4057 Basel
Participation is limited and by personal invitation.
show less
